Free Trial
TSE:REUN

Reunion Neuroscience (REUN) Stock Price, News & Analysis

Reunion Neuroscience logo
C$1.42
-0.04 (-2.74%)
(As of 08/2/2023)

About Reunion Neuroscience Stock (TSE:REUN)

Key Stats

Today's Range
C$1.41
C$1.43
50-Day Range
C$1.42
C$1.42
52-Week Range
C$0.83
C$6.56
Volume
339 shs
Average Volume
12,447 shs
Market Capitalization
C$16.64 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Reunion Neuroscience Inc., a clinical-stage biopharmaceutical company, develops therapeutic solutions for mental health conditions in North America. The company's lead asset includes RE104, a clinical-stage serotonergic psychedelic therapeutic product for antidepressant applications. It is also developing the RE200 series, which comprises molecules that are structurally designed to be similar to classical psychedelics with selective potency at the target serotonin 2A receptor (5HT2A) for potential chronic treatment in various patient populations and indications. The company was formerly known as Field Trip Health Ltd. Reunion Neuroscience Inc. was founded in 2008 and is headquartered in Toronto, Canada.

Receive REUN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Reunion Neuroscience and its competitors with MarketBeat's FREE daily newsletter.

REUN Stock News Headlines

Why are so many Roman statues headless?
2 sentences that change everything you THOUGHT you knew about trading
If you're like most people, on Friday morning you'll probably follow your set routine: Wake up... eat breakfast... go to work... But if you say these two sentences to your broker... you could collect as much as $1,250 on Friday... no matter where you live, whether you're working or already retired. It all has to do with a unique stock market secret that's worked 97% of the time for the past 8 years running.
See More Headlines

REUN Stock Analysis - Frequently Asked Questions

Reunion Neuroscience's stock was trading at C$1.42 at the beginning of 2024. Since then, REUN shares have increased by 0.0% and is now trading at C$1.42.
View the best growth stocks for 2024 here
.

Shares of REUN stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Reunion Neuroscience investors own include Meta Platforms (META) and BioLineRx (BLRX).

Industry, Sector and Symbol

Sector
Medical
Industry
Biotechnology
Sub-Industry
Healthcare
CIK
N/A
Fax
N/A
Employees
190
Year Founded
N/A

Profitability

Net Income
C$-38,100,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$4.86 million
Book Value
C$1.82 per share

Miscellaneous

Free Float
N/A
Market Cap
C$16.64 million
Optionable
Not Optionable
Beta
4.20
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

This page (TSE:REUN) was last updated on 11/5/2024 by MarketBeat.com Staff
From Our Partners